Europe is home to a host of world-leading universal healthcare systems, globally relevant research institutions, and the headquarters of some of the globe’s biggest pharma companies. European science has long had a massive impact, not just for patients on the continent, but globally. However, in recent years Europe has lagged both North America as well…
See Full ReportInFigures
One year on from our last report on the healthcare and life sciences ecosystem in Hong Kong and the Greater Bay Area (GBA), a lot has changed. Major new collaborative infrastructure projects, including the Hong Kong-Shenzhen Innovation and Technology Park and the GBA Clinical Trial Institute, have made significant progress and promise to reshape the…
See Full Report
Under its overarching ‘Vision 2030’ economic diversification plan, Saudi is aiming to play a much greater regional and global role in everything from artificial intelligence to sport and, significantly, healthcare. Ambitious and wide-ranging transformation plans are in place to raise health span and deepen care coverage, while local and female participation in the workforce is…
See Full Report
Rising per capita GDP, enhanced purchasing power, and a surge in inward-bound FDI flows mean that the Indian economy is on its strongest footing in generations. India’s leading industries – notably its life science sector – are reaping the rewards and anticipating rapid market growth. The USD 65 billion Indian pharma market is predicted to…
See Full Report
PharmaBoardroom’s latest report, InFigures: Latin America 2024 features up-to-date datasets from the region’s leading pharma markets and regional production hubs. The combined Latin America and Caribbean market of USD 197 billion looks set to be the fastest growing in the world over the next few years. IQVIA estimates that the Latin American pharma market will…
See Full Report
Healthcare & Life Sciences Review Portugal 2024 – drawing from over 30 interviews with key stakeholders from industry, government, academia, and hospitals – paints a picture of a nation and a sector not without its challenges, but gradually carving out some highly promising niches. Topics covered in this comprehensive and up-to-date new report include deep…
See Full Report
Morocco, and its healthcare sector, have reached a pivotal moment. The North African nation is currently implementing the most ambitious, far-reaching, and comprehensive health system reorganization in its history along with a major shake-up of the regulatory frameworks governing the country’s local pharmaceuticals industry. All of this is occurring within the context of a cross-industry…
See Full Report
Long considered a destination of choice for life science multinationals seeking to tap into the latent potential of Middle Eastern markets, the United Arab Emirates’ pharmaceuticals, medtech and healthcare sectors have all been exhibiting significant growth momentum in the post-pandemic period. This comprehensive new report, based on interviews with government officials, KOLs, representatives of multinational…
See Full Report
Post-COVID and with a national-level strategy in place to bolster its traditional strengths as well as spearhead entry into new sectors, Hong Kong has reason for optimism once again. One of two special administrative regions (SARs) in southern China with separate laws and regulations to the rest of the country, Hong Kong has had to…
See Full Report
It is undeniable that Belgium holds a strong position as a vibrant life sciences hub at the heart of Europe. Although the country itself represents only a mid-sized marketplace, Belgium boasts a robust environment that fosters multinational drug makers as well as home-grown biotechs and is replete with singular expertise. From its strategic position at…
See Full Report
Thanks to a more stable macroeconomic and political footing than at any time in the past 15 years, Greeks once more have cause for cautious optimism about their country’s direction of travel. Many of the half a million educated young people who left the country in search of opportunities elsewhere during the crisis are returning,…
See Full Report
This exclusive new report, bringing together stakeholders from across the Latin American healthcare and life sciences ecosystem, shines a light on a continent, and an industry, poised for increased global relevance in the coming years. While economic and political uncertainty remain facts of life in LatAm, the region also has all the fundamentals of a…
See Full Report